Last reviewed · How we verify
TIP chemotherapy
At a glance
| Generic name | TIP chemotherapy |
|---|---|
| Sponsor | Dragonboat Biopharmaceutical Company Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Durability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular Degeneration
- The Influence of Chemotherapy on Position Sense
- Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue Cancer (PHASE2)
- Quality Of Recovery After Pericapsular Nerve Group (PENG) Block For Hip Hemiarthroplasty Under Spinal Anesthesia (NA)
- Effect of Liposome Bupivacaine Serratus Plane Block on Postoperative Hyperalgesia and Chronic Post-surgical Pain in Patients Undergoing Radical Mastectomy (PHASE1, PHASE2)
- Photodynamic Therapy and Post-Endodontic Pain in Undergraduate-Performed Treatments
- Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery (NA)
- Pain Control After VATS Anatomical Pulmonary Resections (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TIP chemotherapy CI brief — competitive landscape report
- TIP chemotherapy updates RSS · CI watch RSS
- Dragonboat Biopharmaceutical Company Limited portfolio CI